首页> 外文期刊>Circulation. Arrhythmia and electrophysiology >Should implantable cardioverter-defibrillators and permanent pacemakers in patients with terminal illness be deactivated? Deactivating implantable cardioverter-defibrillators and permanent pacemakers in patients with terminal illness. An ethical distinction.
【24h】

Should implantable cardioverter-defibrillators and permanent pacemakers in patients with terminal illness be deactivated? Deactivating implantable cardioverter-defibrillators and permanent pacemakers in patients with terminal illness. An ethical distinction.

机译:患有绝症的患者是否应停用植入式心脏复律除颤器和永久起搏器?停用绝症患者的植入式心脏复律除颤器和永久起搏器。道德上的区别。

获取原文
获取原文并翻译 | 示例
       

摘要

The recently published 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities1 include a discussion of ethical issues surrounding the deactivation of pacemakers, implanted cardioverter-defibrillator (ICDs), and CRT devices in patients who are terminally ill. The authors rightly note that most clinicians make an ethical distinction between deactivating an ICD and deactivating a permanent pacemaker. Programming an ICD so that it will not provide antitachycardia therapy in the event of ventricular tachycardia or ventricular fibrillation in a terminally ill patient who requests this action seems to be widely accepted as morally permissible.2^8 Many patients and physicians find the deactivation of an ICD in this situation as morally equivalent to a "do not resuscitate" order. Deactivation of an ICD in a patient who is dying of a terminal illness, whether cardiac or another condition, prevents the delivery of painful ICD shocks and allows the patient to die of the natural progression of their underlying disease. As such, this action seems a humane withdrawal of a futile medical treatment.
机译:最近发布的《 2008年基于设备的心律异常设备治疗指南》 1讨论了有关在起病末期患者中停用起搏器,植入的心脏复律除颤器(ICD)和CRT设备的伦理问题。作者正确地指出,大多数临床医生在停用ICD和停用永久起搏器之间做出了道德上的区分。对ICD进行编程,使其在需要此操作的绝症患者中发生室性心动过速或心室纤颤时不会提供抗心动过速的治疗,这在道德上似乎已被广泛接受。2^ 8许多患者和医生都发现停用ICD在这种情况下,ICD在道德上等同于“请勿复苏”命令。即将死于心脏病或其他疾病的绝症患者的ICD失活可防止传递ICD痛性休克,并使患者死于其潜在疾病的自然发展。因此,此举似乎是人道地撤消了徒劳的药物治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号